Saudi Journal of Medicine and Public Health · مجلد 1 (1) · 37-46
Background: The integration of artificial intelligence (AI) and robotics into healthcare has the potential to transform various medical applications, enhancing operational efficiency, precision, and patient outcomes. However, ethical considerations surrounding these technologies remain a critical concern. Methods: This paper conducts a comprehensive literature review, examining the current applications of AI and robotics in healthcare, including diagnostics, treatment, rehabilitation, and patient care. Key methodologies analyzed include machine learning algorithms, natural language processing, and robotic-assisted surgical techniques. The review synthesizes findings from recent studies and evaluates the efficacy and challenges associated with these technologies. Results: The analysis reveals significant advancements in AI-driven diagnostic tools, particularly in medical imaging, where algorithms enhance accuracy and reduce human error. Robotics has also shown promise in surgical procedures, rehabilitation, and elder care, improving patient engagement and operational workflows. Despite these advancements, challenges such as data privacy, algorithm transparency, and the need for healthcare professionals’ training in AI technologies persist. Conclusion: The future of medical robotics and AI appears promising, with the potential to revolutionize healthcare delivery. However, addressing ethical, operational, and educational challenges is crucial for successful integration. Ongoing collaboration among technologists, healthcare providers, and policymakers will be essential to navigate these complexities and enhance patient care.
artificial intelligence in healthcaremedical roboticsrobotic surgeryAI-assisted diagnosis
High-resolution computed tomography (HRCT) has emerged as a valuable tool in diagnosing and stratifying COVID-19 patients, especially where RT-PCR results are delayed. The modified CO-RADS classification system helps standardize reporting and assess the likelihood of COVID-19 infection based on imaging findings. Objective: To evaluate the spectrum of HRCT chest findings in confirmed COVID-19 patients using the modified CO-RADS classification and assess the association of radiological severity with clinical outcomes. Methods: This cross-sectional study included 110 COVID-19 patients categorized using the modified CO-RADS system. HRCT findings such as ground-glass opacities, consolidation, and crazy-paving were documented. Clinical variables including oxygen requirement, ICU admission, and hospital stay were compared across CO-RADS categories. Data were analyzed using SPSS version 26. Results: Most patients were categorized as CO-RADS 5 (42.7%) and CO-RADS 6 (21.8%). Ground-glass opacities (82.7%) and consolidation (61.8%) were the most common findings. Patients in CO-RADS 5–6 had significantly higher oxygen needs (69%), ICU admissions (19.7%), and hospital stays >7 days (52.1%). Logistic regression showed CO-RADS 5–6 (OR 6.8, p<0.001), age >50 years (OR 2.9, p=0.004), and comorbidities (OR 3.2, p=0.002) as strong predictors of severe disease. Conclusion: Modified CO-RADS classification effectively reflects both the radiological and clinical severity of COVID-19. Its integration into routine clinical workflow can improve early identification of high-risk patients and guide timely intervention.
The integration of robotic technology and artificial intelligence (AI) in implant dentistry has ushered in a new era of precision and efficiency. This abstract aims to understand the integration, implications, potential, and challenges of robotic technology and AI in implant dentistry. Robotic systems offer unparalleled accuracy in implant placement, reducing human error and improving treatment outcomes. AI algorithms analyze extensive patient data to assist in diagnosis, treatment planning, and implant design, optimizing the overall process. Successful case studies demonstrate improved implant survival rates and patient satisfaction. However, ethical considerations and the balance between human expertise and reliance on technology must be addressed. Ongoing research aims to enhance these technologies and integrate them with digital workflows. Collaboration and knowledge sharing among practitioners, researchers, and industry experts are essential to drive progress and ensure responsible implementation. The future of implant dentistry lies in harnessing the potential of robotics and AI while upholding the highest standards of patient care and ethical practice.
Journal of Biomolecular Structure and Dynamics · مجلد 43 (1) · 211-240
The DNA topoisomerase II (topo II) enzyme plays an important role in the replication, recombination, and repair of DNA. Despite their widespread applications in cancer therapy, new, selective, and potent topo II inhibitors with better pharmaceutical profiles are needed to handle drug resistance and severe adverse effects. In this respect, an array of 36 new anticancer compounds was designed based on a Xanthone core tethered to multifunctional Pyridine-amines and Imidazole scaffold via alkyl chain linkers. An integrated in silico approach was used to understand the structural basis and mechanism of inhibition of the hybrid xanthone derivatives. In this study, we established an initial virtual screening workflow based on pharmacophore mapping, docking, and cancer target association to validate the target selection process. Next, a simulation-based docking was conducted along with pharmacokinetic analysis to filter out the five best compounds (7, 10, 25, 27, and 30) having binding energies within the range of −60.45 to −40.97 kcal/mol. The screened compounds were further subjected to molecular dynamics simulation for 200 ns followed by MM-GBSA and ligand properties analysis to assess the stability and binding affinity to hTOP2α. The top-ranking hits 3,7-bis(3-(2-aminopyridin-3-ylhydroxy)propoxy)-1-hydroxy-9H-xanthen-9-one (ligand 7) and 3,8-bis(3-(2-aminopyridin-3-ylhydroxy)propoxy)-1-hydroxy-9H-xanthen-9-one (ligand 25) were found to have no toxicity, optimum pharmacokinetic and, DFT properties and stable intermolecular interactions with the active site of hTopo IIα protein. In conclusion, further in vitro and in vivo experimental validation of the identified lead molecules is warranted for the discovery of new human Topoisomerase 2 alpha inhibitors.Communicated by Ramaswamy H. Sarma
xanthone derivativesanticancer drug designvirtual screeningmolecular docking
Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology has been applied to solve several of these problems. In this paper, we present a systematic review of the literature focusing on the adoption of blockchain technology in the pharmaceutical industry. We collected, analyzed, qualified, and discussed studies retrieved from seven databases. The initial search yielded 2,185 papers, which were screened, discussed, voted on, critically appraised, and collected by a snowball workflow that finally yielded 38 papers. The blockchain application areas covered in the papers were classified as counterfeit drug prevention, drug distribution, tracking and tracing, and safety and security. The most frequent category was counterfeit drug prevention, which is consistent with the primary objective of the pharmaceutical industry. The newer topics discussed in this study were data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. We discuss issues surrounding each of these topics and research studies, along with their limitations and solutions. We also examine the challenges and future research directions of applying blockchain technology in the pharmaceutical industry.